A gene expression signature identifies two prognostic subgroups of basal breast cancer-Reference-Cited by-同舟云学术

A gene expression signature identifies two prognostic subgroups of basal breast cancer

Published:2010-05-21 Issue:2 Volume:126 Page:407-420
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Sabatier Renaud,Finetti Pascal,Cervera Nathalie,Lambaudie Eric,Esterni Benjamin,Mamessier Emilie,Tallet Agnès,Chabannon Christian,Extra Jean-Marc,Jacquemier Jocelyne,Viens Patrice,Birnbaum Daniel,Bertucci François

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0897-9.pdf

Reference65 articles.

1. Bertucci F, Finetti P, Cervera N et al (2006) Gene expression profiling and clinical outcome in breast cancer. Omics 10:429–443

2. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874

3. Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418–8423

4. Sorlie T, Wang Y, Xiao C et al (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127

5. Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492–2502

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome-based identification of key actin-binding proteins associated with high metastatic potential in breast cancer;Frontiers in Molecular Biosciences;2024-08-30

2. MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer;Cell Death & Disease;2024-07-18

3. CD8⁺ T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer;Molecular Medicine Reports;2024-07-12

4. FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer;EMBO Molecular Medicine;2024-06-26

5. Cancer-associated fibroblast-derived Dickkopf-1 suppresses NK cell cytotoxicity in breast cancer;2024-04-08